300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Tajikistan
Oman
Puerto Rico
Poland
Sudan
Cameroon
Guernsey
Andorra
Colombia
Armenia
China
Kuwait
Costa Rica
Czech Republic
Kenya
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Ames Seed Capital, VC Fund

Ames Seed Capital

VC Fund

Ames, United States

Ames Seed Capital is a pool of private investors.

Total investments:
6
Last investment:
Lead investor:
33%

Last updated:

Industries Ames Seed Capital invests in

SoftwareHealth CareB2BPetPaaS

Stages Ames Seed Capital invests in

SeedSeries BSeries CConvertible Note

Countries Ames Seed Capital invests in

United StatesCanada

Round sizes

Seed $100k–$1.2M

Round size

Seed
$100k–$1.2M

Investment Focus

Industry

  • Software 2 (33%)
  • Health Care 2 (33%)
  • B2B 1 (17%)
  • Pet 1 (17%)
  • PaaS 1 (17%)
See all 17 industries →

Stage

  • Seed 3 (50%)
  • Series B 1 (17%)
  • Series C 1 (17%)
  • Convertible Note 1 (17%)

Country

  • United States 4 (67%)
  • Canada 1 (17%)

Investments

CompanyDescriptionRoundLinks
VetMeasure VetMeasure
VetMeasure is a developer of a wearable animal health technology harness device designed to remotely monitor health conditions in dogs. The company's device provides accurate detection of an animal's health statistics in real-time, enabling veterinarians and owners to monitor an animal's heart and pulse rates, respiration bodytemperature, and humidity to determine an animal's condition following surgical procedures or illnesses. $100K / Seed / Aug 12, 2019
Pitchly Pitchly
Pitchly provides a SaaS platform for non-technical users to create data-infused real-time PowerPoint and Word documents linked to internal business data wherever it may live. Typically, before Pitchly, this work takes place in disconnected and inefficient tools like Excel, Word, PowerPoint, Sharepoint, or IT-owned databases. The platform aggregatesdisparate information sources, making information easy to catalog, find, and produce compelling and relevant data-driven Word and PowerPoint documents. This generates a 93% reduction in time to create data-heavy documents with 100% error reduction; all in half the time it takes to locate information when compared to traditional approaches.Pitchly end-users can even create custom forms to populate data to those original sources to make certain their teams are using the most relevant and up-to-date data. It aggregates digital data sources, such as Excel, SQL, Salesforce, and more, into one normalized tabular view of the data to reference, search, filter, and then integrate into documents and presentations in real-time. The platform gives the ability to easily publish select information from your database(s) on a website, in various digital forms.The company was founded in 2014 and is headquartered in Des Moines, Iowa. $650K / Convertible Note / Mar 31, 2019
automed automed
A world first, automed is paving the way forward for livestock producers of all sizes. With one single system, you can automatically calculate, deliver and record livestock treatments, and effectively manage your operation. Powerful and easy to use, the automed system integrates easily with existing livestock tools and farm management systems. Theautomed device automatically calculates and delivers both fixed and weight based treatments simply by synchronizing with the automed app. $400K / Seed / Aug 01, 2018
FindBoB FindBoB
FindBoB is a growth, transition and succession planning tool for financial advisors and insurance agents, utilizing machine learning and elements of gamification for asset protection. $1.2M / Seed / Dec 22, 2017
NewLink Genetics NewLink Genetics
NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing novel immuno-oncology products to improve the lives of patients with cancer.Founded more than 15 years ago, NewLink Genetics continues to be at the forefront in immuno-oncology treatments led by a diverse group of industry professionals andphysician-scientists. Personal cancer stories inspire their relentless research and development in advancing treatments. Their mission is to change the cancer treatment paradigm and make a difference in patient lives every day. $17M / Series C / Jan 31, 2008
NewLink Genetics NewLink Genetics
NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing novel immuno-oncology products to improve the lives of patients with cancer.Founded more than 15 years ago, NewLink Genetics continues to be at the forefront in immuno-oncology treatments led by a diverse group of industry professionals andphysician-scientists. Personal cancer stories inspire their relentless research and development in advancing treatments. Their mission is to change the cancer treatment paradigm and make a difference in patient lives every day. $8.2M / Series B / Sep 07, 2007

Co-Investors

Iowa Capital Management Iowa Capital Management 2 deals together
Midwest Oilseeds 2 deals together
NLG Advisors 2 deals together
Chicagoland Investors 1 deal together
Global Insurance Accelerator Global Insurance Accelerator 1 deal together
MaRS Investment Accelerator Fund MaRS Investment Accelerator Fund 1 deal together

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Tajikistan
Oman
Puerto Rico
Poland
Sudan
Cameroon
Guernsey
Andorra
Colombia
Armenia
China
Kuwait
Costa Rica
Czech Republic
Kenya
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Ames Seed Capital invest in?

Ames Seed Capital invests primarily in Software, Health Care and B2B startups, most often at Seed and Series B stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Ames Seed Capital's check size?

Ames Seed Capital typically joins rounds of $100k–$1.2M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Ames Seed Capital participates in.

When did Ames Seed Capital last invest?

The most recent investment recorded for Ames Seed Capital closed in Aug 2019. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Ames Seed Capital Ames Seed Capital Find emails